SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Aviron
AVIR 3.155+3.4%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Boyce Burge who wrote (2)5/17/1997 8:25:00 PM
From: Czechsinthemail   of 645
 
Boyce,

Do you have any information on the competitive situation in vaccines? I've heard that North American Vaccine (NVX) is very strong, and I assume other companies have things in the works. I'm curious how Aviron's vaccines will compare with other products offered by other companies. I suppose a friendlier delivery system is worth something--especially for children. My concern is that, as attractive as Aviron's vaccines may be, that they may be outmuscled by larger companies with comparable or superior products.

Anything else you know about how AVIR's products compare?
Thanks.

Baird
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext